[Promotion of organ circulation by raubasine].
D000818:Animals; D001158:Arteries; D001775:Blood Circulation / Q000187:drug effects*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D004077:Digoxin / Q000633:toxicity; D004285:Dogs; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D008750:Methyldopa / Q000494:pharmacology; D009206:Myocardium / Q000032:analysis; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013328:Strophanthins / Q000633:toxicity; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology; D014680:Veins; D015016:Yohimbine / Q000494:pharmacology*
D013328:Strophanthins; D014665:Vasodilator Agents; D015016:Yohimbine; D008750:Methyldopa; D004077:Digoxin; D012110:Reserpine
Die Förderung der Organdurchblutung durch Raubasin.